STAT3 mutation impacts biological and clinical features of T-LGL leukemia-Reference-Cited by-同舟云学术

STAT3 mutation impacts biological and clinical features of T-LGL leukemia

Published:2017-06-27 Issue:37 Volume:8 Page:61876-61889
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Teramo Antonella¹²,Barilà Gregorio¹²,Calabretto Giulia¹²,Ercolin Chiara¹²,Lamy Thierry³,Moignet Aline³,Roussel Mikael⁴,Pastoret Cédric⁴,Leoncin Matteo¹,Gattazzo Cristina¹²,Cabrelle Anna²,Boscaro Elisa¹,Teolato Sara¹,Pagnin Elisa¹,Berno Tamara¹,De March Elena¹,Facco Monica¹²,Piazza Francesco¹²,Trentin Livio¹²,Semenzato Gianpietro¹²,Zambello Renato¹²

Affiliation:

1. Padua University School of Medicine, Department of Medicine, Hematology and Clinical Immunology Branch, Padua, Italy

2. Venetian Institute of Molecular Medicine (VIMM), Padua, Italy

3. Department of Clinical Hematology, University Hospital of Rennes, Rennes, France

4. Biology Department, University Hospital of Rennes, Rennes, France

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncogenic STAT Transcription Factors as Targets for Cancer Therapy: Innovative Strategies and Clinical Translation;Cancers;2024-03-31

2. Large Granular Lymphocytic Leukemia: Clinical Features, Molecular Pathogenesis, Diagnosis and Treatment;Cancers;2024-03-27

3. The constitutive activation of STAT3 gene and its mutations are at the crossroad between LGL leukemia and autoimmune disorders;Blood Cancer Journal;2024-01-18

4. The complex relationship between large granular lymphocyte leukemia and rheumatic disease;Expert Review of Clinical Immunology;2023-12-18

5. TOX as a new diagnostic marker for T cell large granular lymphocytic leukaemia;Histopathology;2023-12-12